US 11,859,009 B2
Antigen binding proteins specifically binding PRAME
Gabriele Pszolla, Tuebingen (DE); Martin Hofmann, Tuebingen (DE); Meike Hutt, Tuebingen (DE); Sebastian Bunk, Tuebingen (DE); Felix Unverdorben, Tuebingen (DE); Frank Schwoebel, Tuebingen (DE); Dominik Maurer, Tuebingen (DE); Maike Jaworski, Tuebingen (DE); Claudia Wagner, Tuebingen (DE); Florian Schwoerer, Tuebingen (DE); and Heiko Schuster, Tuebingen (DE)
Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE)
Filed by Immatics Biotechnologies GmbH, Tuebingen (DE)
Filed on Sep. 22, 2022, as Appl. No. 17/934,303.
Application 17/934,303 is a continuation of application No. 17/736,882, filed on May 4, 2022.
Claims priority of provisional application 63/184,689, filed on May 5, 2021.
Claims priority of application No. 21172351 (EP), filed on May 5, 2021.
Prior Publication US 2023/0091330 A1, Mar. 23, 2023
Int. Cl. C07K 16/30 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01)
CPC C07K 16/30 (2013.01) [C07K 16/2809 (2013.01); C07K 16/468 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01)] 30 Claims
 
1. An antigen binding protein comprising
a complementary determining region (CDR)a1 comprising the amino acid sequence of SEQ ID NO: 16,
a CDRa2 comprising the amino acid sequence of SEQ ID NO: 32,
a CDRa3 comprising the amino acid sequence of SEQ ID NO: 34
a CDRb1 comprising the amino acid sequence of SEQ ID NO: 10,
a CDRb2 comprising the amino acid sequence of SEQ ID NO: 36, and
a CDRb3 comprising the amino acid sequence of SEQ ID NO: 48.